Massive DNA study points to new heart drug targets and a key role for triglycerides
This study's results will have a huge positive impact on Vascepa Rx's, and ANCHOR AdCom/PDUFA. Google "Univ of Mich massive DNA study" and you should find the PR.
Here is a quote from the PR:
"A further analysis of the massive dataset, published as a letter with lead authors Sekar Kathiresan and Ron Do from Harvard University and the Broad Institute, suggests that triglyceride levels have more impact on cardiovascular disease risk than previously thought.
This analysis found that genetic variations that increase triglyceride or LDL-cholesterol levels are also associated with higher incidence of heart disease."